Upcoming Event
2027 NCODA Global Oncology & Haematology Congress
March 10 – March 11, 2027
Spring 2027 | Dublin, Ireland
About the Event
Save the date, join NCODA in Dublin, Ireland in spring of 2027 for the NCODA Global Oncology & Haematology Congress — an international meeting designed to unite leaders in oncology, hematology, diagnostics, and technology for two days of collaboration and innovation in patient-centered cancer care.
Why Participate?
Leading-Edge Education
Gain practical, clinically relevant insights from experts shaping the future of oncology and haematology. Sessions focus on improving treatment sequencing, managing therapy challenges, enhancing patient adherence, and elevating medically integrated oncology practices.
Best Practices You Can Apply Immediately
Learn proven strategies that improve patient outcomes, streamline workflows, reduce medication waste, and strengthen the connection between the care team and the patient.
A Global Professional Network
Connect with physicians, pharmacists, nurses, APPs, technicians, students, and industry partners who share your commitment to advancing cancer care. Build relationships that support collaboration long after the meeting ends.
A Deeper Understanding of NCODA Resources
Discover NCODA’s tools, standards, educational programs, and support initiatives designed specifically for oncology teams. Attendees get hands-on exposure to resources that enhance both patient experience and practice performance.
The Global Congress energizes and empowers professionals at every stage of their career. You’ll leave with new ideas, renewed purpose, and a deeper connection to the mission of improving oncology care worldwide.
Who Should Attend
Oncology & Haematology Professionals
Prescribers, pharmacists, nurses, pharmacy technicians, and administrators committed to advancing patient-centered care.
Trainees
Students, residents, and fellows pursuing professional development in oncology and haematology.
Industry Partners
Representatives from pharmaceutical, life sciences, biotechnology, diagnostics, and technology organizations engaged in supporting and enhancing cancer care.